Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
12.54
+0.32 (2.62%)
Nov 22, 2024, 4:00 PM EST - Market closed
Cullinan Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 22, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 730 | 436 | 483 | 674 | - | - | |
| Market Cap Growth | 150.95% | -9.73% | -28.36% | - | - | - | |
| Enterprise Value | 155 | -25 | -88 | 355 | - | - | |
| Last Close Price | 12.54 | 10.19 | 10.55 | 15.43 | - | - | |
| PE Ratio | - | - | 4.43 | - | - | - | |
| PS Ratio | - | - | - | 35.58 | - | - | |
| PB Ratio | 1.16 | 0.96 | 0.90 | 1.58 | - | - | |
| P/TBV Ratio | 1.55 | 0.96 | 0.90 | 1.59 | - | - | |
| EV/Sales Ratio | - | - | - | 18.75 | - | - | |
| Debt / Equity Ratio | 0.00 | 0.01 | 0.01 | - | - | - | |
| Asset Turnover | - | - | - | 0.06 | - | - | |
| Quick Ratio | 23.88 | 16.60 | 20.77 | 24.73 | 14.68 | 39.09 | |
| Current Ratio | 24.46 | 17.07 | 21.09 | 25.25 | 14.82 | 39.67 | |
| Return on Equity (ROE) | -26.53% | -31.37% | 22.74% | -21.57% | -39.88% | -33.03% | |
| Return on Assets (ROA) | -20.40% | -22.80% | -16.55% | -13.03% | -23.93% | -20.60% | |
| Return on Capital (ROIC) | -21.19% | -23.89% | -17.11% | -13.58% | -25.29% | -21.23% | |
| Earnings Yield | -19.66% | -35.13% | 23.03% | -9.73% | - | - | |
| FCF Yield | -17.37% | -30.85% | -26.46% | -6.44% | - | - | |
| Buyback Yield / Dilution | -17.81% | 10.91% | -8.27% | -116.61% | -2088.17% | -150.89% | |
| Total Shareholder Return | -17.81% | 10.91% | -8.27% | -116.61% | -2088.17% | -150.89% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.